Rate and time to develop first central line-associated bloodstream infections when comparing open and closed infusion containers in a Brazilian hospital

Brazilian Journal of Infectious Diseases

Volumn 13, Issue 5, 2009, Pages 335-340

  Vilins, Margarete ^a   Blecher, Sergio ^a   da Silva, Maria A Maretti ^a   Rosenthal, Victor Daniel ^b   Barker, Kerry ^c   Salomao, Reinaldo ^a,d  

^a HOSPITAL SANTA MARCELINA   (Brazil)

^b Medical College of Buenos Aires   (Argentina)

^c Baxter International   (United States)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bacteremia; Central line associated blood stream infections; Healthcare associated infection; Intensive care unit; Intravascular device

Indexed keywords

ADULT; ARTICLE; BRAZIL; CATHETER INFECTION; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTAINER; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HUMAN; INFECTION RATE; INFECTION RISK; INFUSION SYSTEM; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PROBABILITY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; CENTRAL VENOUS CATHETERIZATION; COMPARATIVE STUDY; INCIDENCE; INSTRUMENTATION; LENGTH OF STAY; MIDDLE AGED; STATISTICS;

BRAZIL; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 77953701805     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702009000500004     Document Type: Article

References (40)

1. Rosenthal VD, Guzman S, Migone O, Crnich CJ. The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: A prospective, matched analysis. Am J Infect Control 2003; 31 (8):475-80.
2. Macias AE, Munoz JM, Bruckner DA, et al. Parenteral infusions bacterial contamination in a multi-institutional survey in Mexico: considerations for nosocomial mortality. Am J Infect Control 1999; 27 (3):285-90.
3. Maki DG, Anderson RL, Shulman JA. In-use contamination of intravenous infusion fluid. Appl Microbiol 1974; 28 (5):778-84.
4. Rosenthal VD, Maki DG, Salomao R, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med 2006; 145 (8):582-91.
5. Rosenthal VD, Maki DG. Prospective study of the impact of open and closed infusion systems on rates of central venous catheter-associated bacteremia. Am J Infect Control 2004; 32 (3):135-41.
6. Maki DG, Rhame FS, Mackel DC, Bennett JV. Nationwide epidemic of septicemia caused by contaminated intravenous products. I. Epidemiologic and clinical features. Am J Med 1976; 60 (4):471-85.
7. Goldmann DA, Dixon RE, Fulkerson CC, et al. The role of nationwide nosocomial infection surveillance in detecting epidemic bacteremia due to contaminated intravenous fluids. Am J Epidemiol 1978; 108 (3):207-13.
8. Munoz JM, Macias AE, Guerrero FJ, et al. [Control of pediatric nosocomial bacteremia by a program based on culturing of parenteral solutions in use]. Salud Publica Mex 1999; 41 Suppl 1:S32-7.
9. Centers for Disease Control. Clinical sepsis and death in a newborn nursery associated with contaminated parenteral medications- Brazil, 1996. MMWR Morb Mortal Wkly Rep 1998; 47 (29):610-2.
10. Matsaniotis NS, Syriopoulou VP, Theodoridou MC, Tzanetou KG, Mostrou GI. Enterobacter sepsis in infants and children due to contaminated intravenous fluids. Infect Control 1984; 5 (10):471-7.
11. Kilian J, Hosch A, Ahnefeld FW, Schmitz JE, Vanek E. [Bacterial contamination as a complication of intravenous therapy in intensive care (author's transl)]. Anaesthesist 1980; 29 (10):559-66.
12. McAllister JC, Buchanan EC, Skolaut MW. A comparison of the safety and efficiency of three intermittent intravenous therapy systems-the minibottle, the minibag and the inline burette. Am J Hosp Pharm 1974; 31 (10):961-7.
13. Emori TG, Culver DH, Horan TC, et al. National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control 1991; 19 (1):19-35.
14. th Ed. Washington DC: American Society of Microbiology; 1991.
15. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16 (3):128-40.
16. Rosenthal VD, McCormick RD, Guzman S, Villamayor C, Orellano PW. Effect of education and performance feedback on handwashing: the benefit of administrative support in Argentinean hospitals. Am J Infect Control 2003; 31 (2):85-92.
17. Rosenthal VD, Guzman S, Pezzotto SM, Crnich CJ. Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina. Am J Infect Control 2003; 31 (7):405-9.
18. Higuera F, Rosenthal VD, Duarte P, et al. The effect of process control on the incidence of central venous catheter-associated bloodstream infections and mortality in intensive care units in Mexico. Crit Care Med 2005; 33 (9):2022-7.
19. Ramirez Barba EJ, Rosenthal VD, Higuera F, et al. Device- associated nosocomial infection rates in intensive care units in four Mexican public hospitals. Am J Infect Control 2006; 34 (4):244-7.
20. Moreno CA, Rosenthal VD, Olarte N, et al. Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium. Infect Control Hosp Epidemiol 2006; 27 (4):349-56.
21. Rosenthal VD, Guzman S, Crnich C. Device-associated nosocomial infection rates in intensive care units of Argentina. Infect Control Hosp Epidemiol 2004; 25 (3):251-5.
22. Diener JR, Coutinho MS, Zoccoli CM. [Central venous catheter- related infections in critically ill patients]. Rev Assoc Med Bras 1996; 42 (4):205-14.
23. Velasco E, Soares M, Byington R, et al. Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in adult surgical cancer patients. Eur J Clin Microbiol Infect Dis 2004; 23 (8):596-602.
24. Stone PW, Braccia D, Larson E. Systematic review of economic analyses of health care-associated infections. Am J Infect Control 2005; 33 (9):501-9.
25. Higuera F, Rangel-Frausto MS, Rosenthal VD, et al. Attributable cost and length of stay for patients with central venous catheter-associated bloodstream infection in Mexico City intensive care units: a prospective, matched analysis. Infect Control Hosp Epidemiol 2007; 28 (1):31-5.
26. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999; 160 (3):976-81.
27. Rello J, Ochagavia A, Sabanes E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000; 162 (3 Pt 1):1027-30.
28. Collignon PJ. Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust 1994; 161 (6):374-8.
29. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271 (20):1598-601.
30. Heiselman D. Nosocomial bloodstream infections in the critically ill. JAMA 1994; 272 (23):1819-20.
31. Rosenthal VD, Guzman S, Orellano PW. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. Am J Infect Control 2003; 31 (5):291-5.
32. Jarvis WR. The evolving world of healthcare-associated bloodstream infection surveillance and prevention: is your system as good as you think? Infect Control Hosp Epidemiol 2002; 23 (5):236-8.
33. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002; 23 (12):759-69.
34. Raad, II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994; 15 (4 Pt 1):231-8.
35. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338 (8763):339-43.
36. Lobo RD, Levin AS, Gomes LM, et al. Impact of an educational program and policy changes on decreasing catheter-associated bloodstream infections in a medical intensive care unit in Brazil. Am J Infect Control 2005; 33 (2):83-7.
37. Mackel DC, Maki DG, Anderson RL, Rhame FS, Bennett JV. Nationwide epidemic of septicemia caused by contaminated intravenous products: mechanisms of intrinsic contamination. J Clin Microbiol 1975; 2 (6):486-97.
38. Maki DG, Martin WT. Nationwide epidemic of septicemia caused by contaminated infusion products. IV. Growth of microbial pathogens in fluids for intravenous infusions. J Infect Dis 1975; 131 (3):267-72.
39. Maki D, Mermel L. Infections due to infusion therapy. In. Bennett JV, Brachman, PS, eds. Hospital Infections. Fourth ed. Philadelphia: Lippincott-Raven; 1998; p. 611-47.
40. Leblebicioglu H, Rosenthal VD, Arikan OA, et al. Device-associated hospital-acquired infection rates in Turkish intensive care units. Findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect 2007; 65 (3):251-7.